ProText Mobility, Inc.
OTC: TXTM0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Plooy Du Dylon
- Employees
- 1
- Headquarters
- Fort Lauderdale, United States
- IPO year
- 2003
- Market cap
- $9.7M
- Website
- https://www.protxtm.com
Loading TXTM…
Loading profile data…Frequently asked questions about TXTM
What does ProText Mobility, Inc. (TXTM) do?
ProText Mobility, Inc., a biotech company, engages in the development of pharmaceutical botanical medicines. Its medicines are formulated with highly-bioavailable plant extracts. The company is based in Fort Lauderdale, Florida.
Where does TXTM trade?
ProText Mobility, Inc. (TXTM) trades on the Other OTC.
What sector is TXTM in?
ProText Mobility, Inc. (TXTM) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of ProText Mobility, Inc.?
Plooy Du Dylon is the chief executive officer of ProText Mobility, Inc. (TXTM).
Where is ProText Mobility, Inc. headquartered?
ProText Mobility, Inc. is headquartered in United States.
Does TXTM pay a dividend?
ProText Mobility, Inc. (TXTM) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TXTM go public?
ProText Mobility, Inc. (TXTM) completed its initial public offering in 2003.